Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 5 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest May 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Roivant Sciences INC paid sponsored hires in similar roles1 certified filing for “Senior Associate, Investments” (Statisticians) in NY: $160k–$160k, median $160k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 5 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest May 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Roivant Sciences INC paid sponsored hires in similar roles
- 1 certified filing for “Senior Associate, Investments” (Statisticians) in NY: $160k–$160k, median $160k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Roivant (Nasdaq: ROIV) is a commercial-stage biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant’s pipeline includes LISRAYA™ (brepocitinib), a potent small molecule inhibitor of JAK1 and TYK2 FDA-approved for the treatment of dermatomyositis in adult patients and also in late-stage development for the treatment of non-infectious uveitis, cutaneous sarcoidosis and lichen planopilaris; IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. We advance our pipeline by creating nimble subsidiaries or “Vants” to develop and commercialize our medicines and technologies. For more information, visit www.roivant.com .
We embrace diversity across all dimensions and levels of the organization, and we strive to ensure every employee is supported in reaching their full potential. We hire motivated people with diverse backgrounds, identities, experiences and skillsets. We are committed to fostering an inclusive culture where all employees feel valued, respected and empowered to create value for patients.
Position Summary
As a Senior Analyst / Associate on Roivant’s Commercial team, you will be directly responsible for building the functions and capabilities behind Roivant’s commercialization engine. This is a rare chance to shape the commercialization of multiple medicines across a range of indications from the ground up, as Roivant prepares to become the next breakout commercial-stage biotech.
This role is built for someone eager to work across the full commercial agenda, including market research, physician and KOL engagement, real-world data analysis, financial modeling, competitive diligence, and other areas, owning end-to-end workstreams and driving recommendations. This is a high-agency position for someone who thrives in a fast-moving and collaborative environment, takes ownership, and runs directly toward hard problems. You will have direct exposure to senior leadership and a front-row seat as your work drives decisions that matter, with real room to grow quickly and take on additional responsibilities.
Responsibilities
• Lead commercial workstreams end to end – scoping key questions, structuring analyses, executing the work, and driving to a recommendation
• Design and run primary and secondary market research to size markets, map patient journeys, and understand competitive dynamics across a variety of disease areas
• Conduct KOL interviews with physicians and market experts, translating qualitative signal into clear implications for commercial strategy and launch planning
• Analyze real-world data such as EHR and claims to pressure-test assumptions and quantify commercial opportunities
• Build bottom-up revenue forecasts and market models, drawing on standard commercial datasets and pricing/policy sources
• Synthesize findings into decision-ready recommendations and presentations that inform strategic decisions prior to and following launches
• Manage relationships with internal stakeholders across Roivant and our Vants, as well as external partners, to keep workstreams on track and to a high standard
• Contribute to cross-functional problem-solving on the highest-priority questions facing Roivant’s commercial-stage assets
Qualifications
• Exceptional record of achievement from a top-tier university
• 3-5 years of experience in a strategy, commercial, or analytical role in life sciences, for example management consulting, a commercial or strategy function at a biopharma or life sciences company, or life sciences-focused
Apply on company site ↗